LABD ETF

$7.57

Returns Overview

1 Month
-39.07%
3 Months
-52.27%
6 Months
-62.93%
YTD
-63.35%
1 Year
-89.37%
3 Years (annualized)
-60.82%
5 Years (annualized)
-46.05%
10 Years (annualized)
-59.41%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would LABD have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

Loading chart data...

3 Months Performance

Loading chart data...

6 Months Performance

Loading chart data...

1 Year Performance

Loading chart data...

Benchmark & Peers

Benchmark
S&P Biotechnology Select Industry Index(^SPSIBI:SP)
This ETF (YTD)
-63.35%
Peer Avg (YTD)
+12.13%
vs Peers
-75.48%

LABD ETF Performance

LABD performance across multiple time periods: 1-month -39.07%, YTD -63.35%, 1-year -89.37%, 3-year -60.82%, 5-year -46.05%, 10-year -59.41%.

LABD returns trail the peer average of 12.13% YTD. With an expense ratio of 1.07%, investors should weigh costs against performance when evaluating this ETF.

LABD performance comparison shows side-by-side returns with another fund. LABD alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-39.07%N/A
3 Months-52.27%N/A
6 Months-62.93%N/A
1 Year-89.37%N/A
3 Years-60.82%N/A
5 Years-46.05%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized